NASDAQ: ANTXRUSSELL2000
AN2 Therapeutics, Inc.
Healthcare · Biotechnology · Headquartered in Menlo Park, US
Price
Loading chart…
Overview
AN2 Therapeutics, Inc. is a biopharmaceutical company currently in its clinical development phase, specializing in the creation of treatments for uncommon, long-term, and severe infectious conditions. A key focus of their pipeline is epetraborole, an investigational oral medication designed for once-daily administration to individuals battling chronic non-tuberculous mycobacterial lung disease. This enterprise was established in 2017 and operates from its headquarters situated in Menlo Park, California.
History & business model
This section is waiting to be written.
InvestWiki is community-edited. Contribute a plain-English history of AN2 Therapeutics, Inc., its business model, key products, and controversies.